## **PINNT AGM 14[th] October 2022 - COI: 157655**
## **1. Welcome and Introduction**
Carolyn Wheatley (CW) hosted the AGM. She welcomed everyone and thanked them for attending.
## **2. Apologies**
Too numerous to list.
## **3. Approval of Minutes of the last AGM held on 9[th] October 2021**
Minutes of the AGM held on 9th October 2021 were agreed and signed.
## **4. Treasurer’s Report**
Donations are higher this year and include, £10k from Calea, £15k Takeda, Anthony Collins £3.5k and Baxter £2k. Some donations are linked to projects as with Baxter. Takeda and Calea supported the refresh of the website, which will continue in 2022/23 together with supporting the position of our admin support.
Expenses remain very low at £24k. Overall profit of £33k. The charity was carrying around £110k of cash at year end.
All donations are gratefully received, the addition of extra donations via Amazon Smile really make a difference to PINNT as well as the individual sponsored events, so thank you very much.
The charity is exceptionally well positioned to incur harder years including loss making as we go through turbulent years ahead with a recession likely and now, we are currently at a loss in 2022 of £4.3k.
PINNT reviews its expenditure at regular intervals in line with practicalities and sustainable factors to maintain the charity.
The trustees are very happy with the financial position of the charity.
## **’ 5** . **Chair s Report**
I am starting my report with positive note, I am pleased to report that our face-to-face meetings have started again. We have also supported some patient/carer events that will become PINNT groups in time.
Our executive committee (EC) met face-to-face in August again, it was great to see each other. We will balance face-to-face meetings with virtual ones as we can be as productive meeting virtually.
In August we had a successful Home Artificial Nutrition awareness week. Great personal stories were shared, many **#thisime #thisisus** posters gave insight into the lives of so many people on HAN. What stood out to PINNT was the many amazing people who are doing their utmost to adjust and live with their feeding and conditions.
During awareness week we named the winners of The Tracy Hill Patient Champion awards. Established in honour of our much love friend and colleague Tracy Hill who we sadly lost earlier this year. The intended one winner, developed into two along with two Certificates of Recognition. Congratulations to Kimberly Pett, Carolyn Wheatley – award winners and Angela Cole and Martine Hartley as Certificate of Recognitions winners. This will be an annual award and we thanks Tracy’s family for their support during this process.
Our website has had a small makeover and will be continuing this for the next 12 months.
PINNT continues to have an active role in advocating for people on HPN, the current landscape is still rocky due to capacity and staffing issues as the virus still impacts supplies and services. There is also engagement on the impact on home enteral tube feeding patients, in terms of supplies and products too. Further work with BAPEN will be coming in the months ahead.
Our advocacy role has allowed us to represent enteral feeding people who face the changes to what feeds they can legally take to Europe when travelling following our departure from the EU. It’s slow but we have given feedback there may be further communication at some point soon.
Our virtual nutrition team launched guidance on ‘Swimming and other recreational water-based activities with an intravenous catheter or an enteral feeding tube’ this year. As a clinical team they were able to offer guidance to ensure that anyone wishing to take part should consider the pros and cons and have a conversation with their clinical team to determine what is best for them.
Our LITRE committee (Looking into the Requirements for Equipment) completed a User Assessment of a new ambulatory PN pump, the report is on the website. LITRE will be meeting tomorrow to carry out another User Assessment on another ambulatory PN pump. This panel provide a vital role as the voice of the users is vital when equipment is being considered for use in the home. Thanks to LITRE for their continued support to our programme of activities.
Thanks to our volunteers who send out the birthday cards. I would like to thank our trustees and EC members for another year of voluntary work for PINNT.
We engaged a new admin support role this year and I am delighted to say that Rachel has fitted into PINNT and will be developing her role within PINNT to support the EC.
We acknowledge the support of our Corporate Partners: Abbott, BD, BBraun, Calea, Eitan Medical, Inspiration Healthcare, Micrel, NG Pod, Nutricia, ICU Medical, Independence Products, Lloyds Clinical Homecare and Nutrinovo.
## **6. Election of EC for the 2022/2023 term**
Following the nomination process I am pleased to report that we have retained the support of key people as well as being able to welcome new volunteers.
We have the following people ready to serve PINNT for the next term of office:
|**Chair**|Carolyn Wheatley|
|---|---|
|**General Secretary**|Steven Pearson-Brown|
|**Treasurer**|Richard Shawyer-Clarke|
|**Membership Sec**|Debbie Phillips|
**Executive Committee** Colette Taylor **Executive Committee** Amy Martin **Executive Committee** Gary Taylor **Executive Committee** Jo Gabbitas
**Any objections to any of the candidates?** None noted.
**In that case I confirm those nominated are duly appointed for the next term of office.** This concludes the official business of the nomination process.
## **8. A.O.B.**
The AGM was officially closed.
DocuSign Envelope ID: 3DA31A0A-D692-4748-A92C-2C21FA08EE6E
|**Charity Name**|**Charity Name**|**Charity Name**|**No (if any)**|
|---|---|---|---|
|**Receipts andpayments accounts**||||
|**For the period**
**from**|Period start date|**To**|Period end date|
## **CC16a**
## **Section A Receipts and payments**
|**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**
**26,185**
**31,470**
**90**
**-**
**-**
**-**
**-**
**-**
**57,745**
**-**
**-**
**-**
**57,745**|**Unrestricted**
**funds**
**to the nearest**
**£**
**26,185**
**31,470**
**90**
**-**
**-**
**-**
**-**
**-**
**57,745**
**-**
**-**
**-**
**57,745**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**26,185**
**31,470**
**90**
**-**
**-**
**-**
**-**
**-**
**57,745**
**-**
**-**
**-**
**57,745**|**Total funds**
**to the nearest £**
**26,185**
**31,470**
**90**
**-**
**-**
**-**
**-**
**-**
**57,745**
**-**
**-**
**-**
**57,745**|**Last year**
**to the nearest £**|
|---|---|---|---|---|---|---|---|---|---|
|Donations|**26,185**||||||||**-**|
|Corporate Donations|**31,470**||||||||**-**|
|Interest|**90**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
|**_Sub total_**_(Gross income for_
_AR)_|**57,745**||||||||**-**|
|||||||||||
|**A2 Asset and investment sales,**
**(see table).**||||||||||
||**-**|||||||||
||**-**||||||||**-**|
|**_Sub total_**|**-**||||||||**-**|
|**_Total receipts_**
**A3 Payments**||||||||||
||||||||||**-**|
|||||||||||
|Travel/MeetingRooms|**716**||**-**||**-**||**716**||**-**|
|PPP Prizes|**458**||**-**||**-**||**458**||**-**|
|Admin/Postage/Sub/Telephone|**8,815**||**-**||**-**||**8,815**||**-**|
|Advertising|**11,292**||**-**||**-**||**11,292**||**-**|
|Professional Fees|**2,307**||**-**||**-**||**2,307**||**-**|
|General|**1,292**||**-**||**-**||**1,292**||**-**|
|IT and Software|**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_ **|**24,881**||**-**||**-**||**24,881**||**-**|
|||||||||||
|**A4 Asset and investment**
**purchases, (see table)**||||||||||
||**-**|||||||||
||**-**|||||||||
|**_Sub total_ **|**-**||||||||**-**|
|**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||||||
||||||||||**-**|
|||||||||||
||**32,864**||**-**||**-**||**32,864**||**-**|
||**-**|
|**-**|
|**-**||**-**||**-**|
||**91,848**||**-**||**-**||**91,848**||**-**|
||**124,712**||**-**||**-**||**124,712**||**-**|
CCXX R1 accounts (SS)
2/21/2023
1
DocuSign Envelope ID: 3DA31A0A-D692-4748-A92C-2C21FA08EE6E
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Current Account
Savings Account
Acure for Invoies
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))|Current Account
Savings Account
Acure for Invoies
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))|**Unrestricted**
**funds**
**to nearest £**
**22,753**
**100,030**
**1,929**
**124,712**
OK
**Unrestricted**
**funds**
**to nearest £**|**Unrestricted**
**funds**
**to nearest £**
**22,753**
**100,030**
**1,929**
**124,712**
OK
**Unrestricted**
**funds**
**to nearest £**|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**|**Endowment**
**funds**
**to nearest £**|
|---|---|---|---|---|---|---|---|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||OK|
||||||||**Endowment**
**funds**
**to nearest £**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||**Details**||**Fund to which**
**asset belongs**||**Cost (optional)**||**Current value**
**(optional)**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||**Details**||**Fund to which**
**asset belongs**||**Cost (optional)**||**Current value**
**(optional)**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||**Details**||**Fund to which**
**liability relates**||**Amount due**
**(optional)**||**When due**
**(optional)**|
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||Signature||Print Name
Richard Shawyer|||||
||||||||Date of
approval|
||||Richard Shawyer|||||
||||||||2/21/2023|
CCXX R2 accounts (SS)
2/21/2023
2